Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 404761, 7 pages
http://dx.doi.org/10.1155/2011/404761
Research Article

Panax notoginseng Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice

1Department of Internal Medicine, China Medical University Beigang Hospital, Yunlin 651, Taiwan
2Institute of Molecular Biology, National Chung Cheng University, Chiayi 62102, Taiwan
3Department of Chinese Medicine, China Medical University Beigang Hospital, Yunlin 651, Taiwan
4Department of Respiratory Therapy, China Medical University, Taichung 40402, Taiwan
5College of Medical Science and Technology, Chung Shan Medical University, Taichung 40204, Taiwan
6Division of Pulmonary and Critical Care Medicine, Chia-Yi Christian Hospital, Chiayi 600, Taiwan
7Department of Life Sciences, National, Chung Hsing University, Taichung 402, Taiwan

Received 23 October 2010; Revised 3 January 2011; Accepted 10 January 2011

Copyright © 2011 Kuen-Daw Tsai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. J. Gross and G. W. Hunninghake, “Idiopathic pulmonary fibrosis,” New England Journal of Medicine, vol. 345, no. 7, pp. 517–525, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Zhang, M. D. Rekhter, D. Gordon, and S. H. Phan, “Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis: a combined immunohistochemical and in situ hybridization study,” American Journal of Pathology, vol. 145, no. 1, pp. 114–125, 1994. View at Google Scholar · View at Scopus
  3. C. Kuhn and J. A. McDonald, “The roles of the myofibroblast in idiopathic pulmonary fibrosis: ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis,” American Journal of Pathology, vol. 138, no. 5, pp. 1257–1265, 1991. View at Google Scholar · View at Scopus
  4. J. C. Horowitz and V. J. Thannickal, “Idiopathic pulmonary fibrosis: new concepts in pathogenesis and implications for drug therapy,” Treatments in Respiratory Medicine, vol. 5, no. 5, pp. 325–342, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Selman, T. E. King, and A. Pardo, “Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy,” Annals of Internal Medicine, vol. 134, no. 2, pp. 136–151, 2001. View at Google Scholar · View at Scopus
  6. J. C. Horowitz and V. J. Thannickal, “Epithelial-mesenchymal interactions in pulmonary fibrosis,” Seminars in Respiratory and Critical Care Medicine, vol. 27, no. 6, pp. 600–612, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Selman and A. Pardo, “The epithelial/fibroblastic pathway in the pathogenesis of idiopathic pulmonary fibrosis: tying loose ends,” American Journal of Respiratory Cell and Molecular Biology, vol. 29, no. 3, pp. S93–S97, 2003. View at Google Scholar · View at Scopus
  8. S. H. Phan and S. L. Kunkel, “Lung cytokine production in bleomycin-induced pulmonary fibrosis,” Experimental Lung Research, vol. 18, no. 1, pp. 29–43, 1992. View at Google Scholar · View at Scopus
  9. X. Chen, M. Zhou, Q. Li et al., “Sanchi for acute ischaemic stroke,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD006305, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Chan, G. N. Thomas, and B. Tomlinson, “Protective effects of trilinolein extracted from Panax notoginseng against cardiovascular disease,” Acta Pharmacologica Sinica, vol. 23, no. 12, pp. 1157–1162, 2002. View at Google Scholar · View at Scopus
  11. T. B. Ng, “Pharmacological activity of sanchi ginseng (Panax notoginseng),” Journal of Pharmacy and Pharmacology, vol. 58, no. 8, pp. 1007–1019, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Rhule, S. Navarro, J. R. Smith, and D. M. Shepherd, “Panax notoginseng attenuates LPS-induced pro-inflammatory mediators in RAW264.7 cells,” Journal of Ethnopharmacology, vol. 106, no. 1, pp. 121–128, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. S. H. Chang, Y. Choi, J. A. Park et al., “Anti-inflammatory effects of BT-201, an n-butanol extract of Panax notoginseng, observed in vitro and in a collagen-induced arthritis model,” Clinical Nutrition, vol. 26, no. 6, pp. 785–791, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Rhule, B. Rase, J. R. Smith, and D. M. Shepherd, “Toll-like receptor ligand-induced activation of murine DC2.4 cells is attenuated by Panax notoginseng,” Journal of Ethnopharmacology, vol. 116, no. 1, pp. 179–186, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. G. Zhang, H. G. Zhang, G. Y. Zhang et al., “Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action,” Clinical and Experimental Pharmacology and Physiology, vol. 35, no. 10, pp. 1238–1244, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. H. W. Jung, U. K. Seo, J. H. Kim, K. H. Leem, and Y. K. Park, “Flower extract of Panax notoginseng attenuates lipopolysaccharide-induced inflammatory response via blocking of NF-κB signaling pathway in murine macrophages,” Journal of Ethnopharmacology, vol. 122, no. 2, pp. 313–319, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. B. Wan, S. M. Y. Lee, J. D. Wang et al., “Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-α-induced endothelial adhesion molecule expression and monocyte adhesion,” Journal of Agricultural and Food Chemistry, vol. 57, no. 15, pp. 6692–6697, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. X. S. Xie, M. Yang, H. C. Liu et al., “Influence of ginsenoside Rg1, a panaxatriol saponin from Panax notoginseng, on renal fibrosis in rats with unilateral ureteral obstruction,” Journal of Zhejiang University B, vol. 9, no. 11, pp. 885–894, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. W. H. Park, S. K. Lee, and C. H. Kim, “A Korean herbal medicine, Panax notoginseng, prevents liver fibrosis and hepatic microvascular dysfunction in rats,” Life Sciences, vol. 76, no. 15, pp. 1675–1690, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. X. D. Peng, L. L. Dai, C. Q. Huang, C. M. He, B. Yang, and L. J. Chen, “Relationship between anti-fibrotic effect of Panax notoginseng saponins and serum cytokines in rat hepatic fibrosis,” Biochemical and Biophysical Research Communications, vol. 388, no. 1, pp. 31–34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Geng, W. Peng, Y. Huang, H. Fan, and S. Li, “Ginsenoside-Rg1 from Panax notoginseng prevents hepatic fibrosis induced by thioacetamide in rats,” European Journal of Pharmacology, vol. 634, no. 1–3, pp. 162–169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Rong, Y. Chen, M. He, and X. Zhou, “Panax notoginseng saponins attenuate acute lung injury induced by intestinal ischaemia/reperfusion in rats,” Respirology, vol. 14, no. 6, pp. 890–898, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. B. de Rochemonteix-Galve, J. M. Dayer, and A. F. Junod, “Fibroblast-alveolar cell interactions in sarcoidosis and idiopathic pulmonary fibrosis: evidence for stimulatory and inhibitory cytokine production by alveolar cells,” European Respiratory Journal, vol. 3, no. 6, pp. 653–664, 1990. View at Google Scholar · View at Scopus
  24. G. Kollias, E. Douni, G. Kassiotis, and D. Kontoyiannis, “The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease,” Annals of the Rheumatic Diseases, vol. 58, no. 1, pp. I32–I39, 1999. View at Google Scholar · View at Scopus
  25. H. S. Zhang and S. Q. Wang, “Notoginsenoside R1 from Panax notoginseng inhibits TNF-α-induced PAI-1 production in human aortic smooth muscle cells,” Vascular Pharmacology, vol. 44, no. 4, pp. 224–230, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Ashcroft, J. M. Simpson, and V. Timbrell, “Simple method of estimating severity of pulmonary fibrosis on a numerical scale,” Journal of Clinical Pathology, vol. 41, no. 4, pp. 467–470, 1988. View at Google Scholar · View at Scopus
  27. A. L. A. Katzenstein and J. L. Myers, “Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 4, pp. 1301–1315, 1998. View at Google Scholar · View at Scopus
  28. P. G. Tsoutsou, K. I. Gourgoulianis, E. Petinaki et al., “Cytokine levels in the sera of patients with idiopathic pulmonary fibrosis,” Respiratory Medicine, vol. 100, no. 5, pp. 938–945, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Agostini and C. Gurrieri, “Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis,” Proceedings of the American Thoracic Society, vol. 3, no. 4, pp. 357–363, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Wu, S. S. Zhang, and G. F. Kang, “Effects of panax notoginseng saponins on the expression of tumor necrosis factor alpha and secretion phospholipase A2 in rats with liver fibrosis,” Zhonghua Gan Zang Bing Za Zhi, vol. 11, no. 1, pp. 51–52, 2003. View at Google Scholar · View at Scopus
  31. B. H. Su, Z. Li, J. M. Fan, M. Wang, and R. Tang, “Effects of panax notoginseng saponins on the process of renal interstitial fibrosis after unilateral ureteral obstruction in rats,” Journal of Sichuan University, vol. 36, no. 3, pp. 368–371, 2005. View at Google Scholar · View at Scopus
  32. Y. Wei, J. M. Fan, and L. P. Pan, “Effect of Panax notoginseng saponins on human kidney fibroblast,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 22, no. 1, pp. 47–49, 2002. View at Google Scholar · View at Scopus
  33. M. A. Olman, K. E. White, L. B. Ware et al., “Pulmonary edema fluid from patients with early lung injury stimulates fibroblast proliferation through IL-1β-induced IL-6 expression,” Journal of Immunology, vol. 172, no. 4, pp. 2668–2677, 2004. View at Google Scholar